The Multiple Myeloma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

SOHO 2019 | Are we ready to use MRD for treatment decisions in patients with MM?

Sep 17, 2019

During SOHO 2019, Houston, US, the Multiple Myeloma Hub were pleased to host a debate between Thomas G. Martinand Jeffrey L. Wolf, both from the University of California San Francisco, San Francisco, US, on whether we are ready to use MRD for treatment decisions in patients with multiple myeloma (MM).

The interview is a continuation of the debate that started during the session on MM. Concluding, the opponents agree that the definition of MRD needs to be more specific and that, although it may not be ready for prime time use, we are very close.

Are we ready to use MRD for treatment decisions in patients with MM?